Janssen Alzheimer, Elan Pharmaceuticals and Genomic Health Discuss Clinical Data Integration at Fifth Silicon Valley BioTalks

Clinical Trial Study Experts and Healthcare IT Experts from Leading Pharma and Biotech Companies Share Best Practices on Winning Strategies For Clinical Data Integration

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Fifth Silicon Valley BioTalks on Winning Strategies for Clinical Data Integration

Fifth Silicon Valley BioTalks on Winning Strategies for Clinical Data Integration

We need to bridge systems together to save time, energy and money to enter and analyze the data.

Sunnyvale, CA (PRWEB) November 30, 2012

Over fifty healthcare industry professionals and Healthcare IT experts attended the fifth session of the Silicon Valley BioTalks, a quarterly panel discussion and networking venue co-sponsored by Clinovo and SNR Denton. The event took place on November 8th, 2012, and addressed the challenges of data integration for the clinical trial industry.

The event focused on Winning Strategies For Clinical Data Integration, a topic at heart for life science professionals. The panelists with up to 25 years experience in the pharma and biotech industry, shared best practices around systems integration, clinical research efficiencies, and healthcare IT databases.

Wessam Sonbol (Clinovo, Senior Data Management Study Lead, and Founder of VOXCE) moderated the panel, composed by: Joe Warlow (Janssen Alzheimer Immunotherapy, Director, Clinical Data Management), Lauren Intagliata (Genomic Health, Associate Director, Clinical Data Management) and Chito Hernandez (Elan Pharmaceuticals, Vice President of Biometrics and Information Management).

Clinovo posted the recording of the discussion online. Some of the key highlights include strategies to favor systems integration: ”We need to bridge systems together to save time, energy and money to enter and analyze the data”, explains Lauren Intagliata, Associate Director, Clinical Data Management at Genomic Health. Chito Hernandez, Vice President of Biometrics and Information Management at Elan Pharmaceuticals, points out the importance of clinical standards such as CDISC SDTM and CDASH: “Data standards will allow for development of tools making data integration more intuitive”, states Chito.

Clinovo, CRO with headquarters in Sunnyvale, has ten years of expertise in systems integration. Clinovo recently integrated ClinCapture, Clinovo’s open source Electronic Data Capture (EDC) system, with an open source customized ePro. This integrated solution reduces both time and cost of data collection and increases data quality and consistency.

The Silicon Valley BioTalks is a premier venue for pharmaceutical and medical device professionals to build their knowledge and expertise. For the first time, the panel discussion was simultaneously streamed online for attendees outside California. "Thank you for making this very instructive discussion available to everybody!" said an attendee.

Since its launch in June 2011, the Silicon Valley BioTalks gathered over 250 clinical trials professionals from the Bay Area and beyond. Clinovo and the co-organizers invited 20 influent industry experts from leading life science companies including Roche, Affymax, Janssen Alzheimer and Elan Pharmaceuticals. The next session will take place in February 2013.

Contact information
Sophie McCallum
Marketing Manager at Clinovo
408-773-6258
sophie.mccallum(at)clinovo.com

About Clinovo
Clinovo partners with life science companies to streamline their clinical trials, leveraging years of expertise in systems integration, open source technology and industry standards. Clinovo provides Staffing Solutions, eClinical Systems and Biometrics Services including Clinical Data Management, Electronic Data Capture, CDISC mapping and SAS Programming.

About the Silicon Valley BioTalks
Silicon Valley BioTalks is a series of quarterly networking and expert discussion events. Top-tier panelists from leading pharmaceutical, biotechnology and medical device companies share their expertise and best practices on specific industry challenges. The previous sessions of the Silicon Valley BioTalks addressed the following topics: Implementing Adaptive Clinical Trials, Run Efficient Clinical Trials With Open Source Technologies, How CDISC standards streamline clinical trials and FDA Submission: The New Rules.


Contact